• e-Learning

    Two interactive modules to help with the treating patients with atrial fibrillation who present with ACS and/or require PCI, and the AUGUSTUS trial in the treatment of patients with atrial fibrillation who present with ACS and/or require PCI.

  • Interview with Professor Renato Lopes

    Learn the details of the ground-breaking AUGUSTUS trial from Principal Investigator Renato Lopes

  • Interview with Professor Rob Storey

    Hear Professor Storey’s opinion on the changing treatment landscape for stroke prevention in patients with atrial fibrillation and ACS and/or PCI

  • AF: A common arrhythmia

    Atrial fibrillation, the most common sustained cardiac arrhythmia, presents with various symptoms and severities

  • Thrombi can cause ischaemic stroke

    Most atrial fibrillation patients should receive anticoagulants to prevent thrombi embolising from the atria to the cerebral vasculature

  • AF increases stroke risk five-fold compared with controls

    Atrial fibrillation-related stroke is more likely to cause death and disability than stroke from other causes

  • Atherosclerosis

    Recent studies support care of atrial fibrillation patients presenting with acute coronary syndrome or who undergo percutaneous coronary or valve interventions

  • ESC Congress 2019

    Our team attended the ESC Congress 2019 to bring daily reports

    View all daily round-ups here


Welcome to the Anticoagulation Therapy for Stroke Prevention Learning Zone, which introduces the intimate relationship between stroke and atrial fibrillation (AF). Warfarin reduces stroke risk in AF patients, but commonly causes major bleeds and other side effects. The need for regular monitoring and the risk of interactions often makes warfarin difficult to use clinically. Oral non-vitamin K antagonists transformed anticoagulant therapy for non-valvular AF offering improved efficacy and tolerability compared with warfarin. 



Learn more about the treating patients with atrial fibrillation who present with ACS and/or require PCI and the AUGUSTUS trial in 2 interactive learning modules



Learn about the management options for atrial fibrillation using invasive treatment and anticoagulants

Anticoagulation guidelines

Anticoagulation guidelines

Find out what the European and American guidelines advise for managing your patients with atrial fibrillation

This Learning Zone reviews the epidemiology, pathophysiology, diagnosis and management of atrial fibrillation, including the latest anticoagulant guidelines, to help you balance the risks and benefits of the various invasive and pharmacological options. The Learning Zone helps you deliver optimal care and prevent strokes in your patients living with common sustained cardiac arrhythmia.

Login/ Register Maximise Minimise